Wellington Management Group’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Hold |
888,130
| – | – | ﹤0.01% | 1704 |
|
|
2025
Q1 | $1.8M | Hold |
888,130
| – | – | ﹤0.01% | 1582 |
|
|
2024
Q4 | $5.35M | Hold |
888,130
| – | – | ﹤0.01% | 1334 |
|
|
2024
Q3 | $6.22M | Hold |
888,130
| – | – | ﹤0.01% | 1277 |
|
|
2024
Q2 | $5.15M | Hold |
888,130
| – | – | ﹤0.01% | 1314 |
|
|
2024
Q1 | $6.35M | Hold |
888,130
| – | – | ﹤0.01% | 1274 |
|
|
2023
Q4 | $4.37M | Hold |
888,130
| – | – | ﹤0.01% | 1340 |
|
|
2023
Q3 | $8.49M | Hold |
888,130
| – | – | ﹤0.01% | 1148 |
|
|
2023
Q2 | $11.5M | Hold |
888,130
| – | – | ﹤0.01% | 1071 |
|
|
2023
Q1 | $11.1M | Sell |
888,130
-12,019
| -1% | -$151K | ﹤0.01% | 1074 |
|
|
2022
Q4 | $9.99M | Buy |
+900,149
| New | +$9.99M | ﹤0.01% | 1087 |
|